Journals / Ege Klinikleri Tıp Dergisi / 2021 / Cilt: 59 - Sayı: 2

The Association of Lung Cancer and Type 2 Diabetes Mellitus in COPD Phenotypes: Comparative Study

KOAH Fenotiplerind Akciğer Kanseri ve Tip 2 Diyabet Mellitus İlişkisi: Karşılaştırmalı Çalışma

Pages
1–7
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Emphyematous phenotype of COPD with T2DM is an independent risk factor for lung cancer and histological subtypes and also haselevated lung cancer risk than non emphyematous phenotype significantly.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: We aimed to investigate the relationship of lung cancer with phenotypes of Chronic obstructive pulmonary disease (COPD)with type 2 diabetes mellitus (T2DM).
📊
Key Findings & Data:Method: This retrospective analysis was applied on type 2 diabetic patients with COPD.
💡
Conclusion & Impact:Conclusion: Emphyematous phenotype of COPD with T2DM is an independent risk factor for lung cancer and histological subtypes and also haselevated lung cancer risk than non emphyematous phenotype significantly.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: We aimed to investigate the relationship of lung cancer with phenotypes of Chronic obstructive pulmonary disease (COPD)with type 2 diabetes mellitus (T2DM). Method: This retrospective analysis was applied on type 2 diabetic patients with COPD. Non-emphysematous type COPD with T2DM and lung cancer associated with JAK-STAT and ERK pathways which plays a role in inflammation and apoptosis.Totally 1764 patients have evaluated and 396patient which have COPD with T2DM were evaluated in different phenotypes. Logistic regression analysis was performed to estimate β, ORs and 95% CIs for lung cancer and for each histological subtype associated with COPD phenotypes. Results: The emphyematous phenotype of COPD significantly correlated with the risk of lung cancer (OR 1.00, 95% CI 0.94-1.27)and histological subtypes (OR 2.11, 95% CI 2.02-3.75) than non emphysematous phenotype COPD. Squamous carcinoma and small cell lung cancer (SCLC) were observed in emphysema phenotype patients than non emphysematous phenotype (OR 1.84, 95% CI 1.36–2.11;OR 1.75, 95% CI 1.44– 2.65). Conclusion: Emphyematous phenotype of COPD with T2DM is an independent risk factor for lung cancer and histological subtypes and also haselevated lung cancer risk than non emphyematous phenotype significantly.

Özet

Giriş: Çalışmamızda Akciğer kanserinin, Kronik obstrüktif akciğer hastalığı (KOAH) ile tip 2 diabetes mellitus (T2DM) fenotipleri arasındaki ilişkiyi araştırmayı amaçladık. Metod : Bu retrospektif analiz, KOAH'lı tip 2 diyabetik hastalara uygulanmıştır. T2DM'li amfizematöz olmayan tip KOAH ve akciğer kanseri arasındaki ilişki inflamasyon ve apoptozda rol oynayan JAK-STAT ve ERK yolaklarıyla ilişkilidir.Toplam 1764 hasta değerlendirildi ve T2DM ile KOAH olan farklı fenotiplerde 396 hasta değerlendirildi. Akciğer kanseri için ve KOAH fenotipleriyle ilişkili her histolojik alt tip için β, OR'leri ve% 95 CI'leri analiz etmek için lojistik regresyon analizi gerçekleştirildi. Sonuçlar: KOAH'ın amfizematöz fenotipinde, amfizematöz olmayan fenotip’e göre akciğer kanseri riski (OR 1.00,% 95 CI 0.94-1.27) idi ve histolojik alt tipler arasında ise (OR 2.11,% 95 CI 2.02-3.75) anlamlı ilişki mevcuttur. Amfizematöz fenotipli hastalarda amfizemli olmayan fenotipe göre skuamöz karsinom ve küçük hücreli akciğer kanseri daha sıklıkla (SCLC) gözlendi (OR 1.84,% 95 CI 1.36–2.11;OR 1.75,% 95 CI 1.44–2.65). Sonuç : T2DM'li amfizematöz KOAH fenotipi, akciğer kanseri ve histolojik alt tipler için bağımsız bir risk faktörüdür ve ayrıca amfizematöz olmayan fenotipe göre akciğer kanseri riski önemli ölçüde artmıştırv

🔖

Cite This Article

YORMAZ, B. (2022). The Association of Lung Cancer and Type 2 Diabetes Mellitus in COPD Phenotypes: Comparative Study. Ege Klinikleri Tıp Dergisi, Cilt: 59 - Sayı: 2, 1–7. https://ajindex.com/articles/495599

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Siegel RL, Miller KD et al. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30
  2. Chen WQ, Zheng RS, Zeng HM et al. Epidemiology of lung cancer in China. Thorac Cancer. 2015;6(2):209–215 3.Dai J, Yang P, Cox A, et al. Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective. Oncotarget. 2017;8(11):18513
  3. Loganathan RS, Stover DE, Shi Wet al. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest. 2006;129(5):1305-12. 5.Young RP, Hopkins RJ, Christmas Tet al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. European Respiratory Journal. 2009;34(2):380-6. 6.Lee CT, Mao IC, Lin CH et al. Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide populationbased study. Eur J Clin Investig. 2013;43(11):1113–9 7. Houghton AM. Mechanistic links between COPD and lung cancer.Nat Rev Cancer. 2013;13(4):233–245. 8. de-Torres JP, Sanchez-Salcedo P, Bastarrika G, et al. Telomere length,COPD and emphysema as risk factors for lung cancer. Eur Respir J.2017;49(1):1601521
  4. MacNee W. Computed tomography-derived pathological phenotypes in COPD. Eur Respir J. 2016;48(1):10–13. 10. de Vegt F, Dekker JM, Jager Aet al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn study. JAMA 285(16):2109– 2113. https://doi.org/10.1001/jama.285.16.2109 11.Kloth C, Thaiss WM, Ditt H et al. Segmental bronchi collapsibility: computed tomography-based quantification in patients with chronic obstructive pulmonary disease and correlation with emphysema phenotype, corresponding lung volume changes and clinical parameters. Thorac Dis. 2016 Dec;8(12):3521-3529. doi: 10.21037/jtd.2016.12.20.PMID: 28149545 12.Henschke CI, Mccauley DI, Yankelevitz DF et al. EarlyLung Cancer Action Project: overall design and findings from baseline screening. Cancer 1999; 354:99–105 13.Society F, Austin JHM, Hogg JCet al. Chronic Obstructive Pulmonary Disease: A Statement of the Fleishner Society. Radiology 2015; 277. 14.Rasmussen SM, Brok J, Backer V et al. Association between chronic obstructive pulmonary disease and type 2 diabetes: a systematic review and meta-analysis. Copd. 2018;15(5):526–35. 15.Mannino DM, Thorn D, Swensen A et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J.2008;32(4):962–9. 16.M.K. Han, M.T. Dransfield, F. Martinez, Chro